Mercator Medical (WAR:MRC) Other Current Receivables: zł5.4 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:MRC Mercator Medical SA WAR:MRC
63 GF Score
Price zł53.40
GF Value zł51.87
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Mercator Medical Other Current Receivables?

Mercator Medical WAR:MRC -0.56% 63 Other Current Receivables is zł5.4 Mil as of Mar. 2026. GuruFocus rates WAR:MRC with a GF Score™ of 63/100 and a GF Value™ of zł51.87 (Fairly Valued). The stock has 2 warning signs investors should review.

Mercator Medical's Other Current Receivables for the quarter that ended in Mar. 2026 was zł5.4 Mil.

Mercator Medical's quarterly Other Current Receivables declined from Sep. 2025 (zł61.92 Mil) to Dec. 2025 (zł0.25 Mil) but then increased from Dec. 2025 (zł0.25 Mil) to Mar. 2026 (zł5.44 Mil).

Mercator Medical's annual Other Current Receivables increased from Dec. 2023 (zł0.43 Mil) to Dec. 2024 (zł53.40 Mil) but then declined from Dec. 2024 (zł53.40 Mil) to Dec. 2025 (zł0.25 Mil).

Mercator Medical Other Current Receivables Related Terms

Mercator Medical Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Mercator Medical's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mercator Medical Other Current Receivables Chart

Mercator Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.35 0.40 0.43 53.40 0.25

Mercator Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.92 82.43 61.92 0.25 5.44
WAR:MRC
63GF Score
Mercator Medical SA WAR:MRC
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mercator Medical Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of zł5.4 Mil mean?
Mercator Medical (WAR:MRC) has a Other Current Receivables of zł5.4 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Mercator Medical and its competitors.
Is Mercator Medical's Other Current Receivables too high?
Mercator Medical's current Other Current Receivables is zł5.4 Mil. Overall, Mercator Medical has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's Other Current Receivables compare to ISRG and BDX?
Mercator Medical's Other Current Receivables of zł5.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Mercator Medical and its competitors. Mercator Medical's current Other Current Receivables is zł5.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Based on GuruFocus' analysis, Mercator Medical (WAR:MRC) is currently considered Fairly Valued. The stock's GF Value™ is zł51.87, compared to a current price of zł53.40 — trading 2.9% above its estimated fair value. The current Other Current Receivables is zł5.4 Mil. Mercator Medical's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Mercator Medical (WAR:MRC), the current Other Current Receivables is zł5.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mercator Medical (WAR:MRC) Overvalued in 2026?

Based on GuruFocus' analysis, Mercator Medical stock appears to be overvalued. The current stock price of zł53.40 is trading 2.9% above its estimated GF Value™ of zł51.87. GuruFocus considers Mercator Medical to be Fairly Valued.

Key valuation signals for WAR:MRC:

  • Other Current Receivables: zł5.4 Mil
  • GF Value™: zł51.87 vs. price of zł53.40 (2.9% above fair value)
  • GF Score™: 63/100 with 2 warning signs

No single metric tells the full story. See the WAR:MRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mercator Medical Business Description

Other Exchanges MM2:Germany
Address Ulica H. Modrzejewska 30, Krakow, POL, 31-327
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
63GF Score

Get the complete analysis for WAR:MRC

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł53.40
Price
zł51.87
GF Value